Vimarsana
Biggest News Aggregation in the World

Page 3 - Decipher Prostate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Decipher Prostate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Decipher Prostate Today - Breaking & Trending Today

Veracyte Announces Multiple Studies Reinforcing the Value of Decipher Prostate Testing Will Be Presented at ASTRO 2023 - Vimarsana News

Veracyte Announces Multiple Studies Reinforcing the Value of Decipher Prostate Testing Will Be Presented at ASTRO 2023

Veracyte, Inc. announced that six abstracts highlighting new data from studies evaluating the company’s Decipher Prostate Genomic Classifier and related capabilities will be presented, three as...

Veracyte, Inc. (NASDAQ:VCYT) Q1 2023 Earnings Call Transcript - Vimarsana News

Veracyte, Inc. (NASDAQ:VCYT) Q1 2023 Earnings Call Transcript

Operator: Good day and thank you for standing by. Welcome to the Veracyte First Quarter 2023 Financial Results Webcast. At this time, all participants are in listen-only mode.

New Artificial Intelligence Tool Can Diagnose Colon Cancer - Vimarsana News

New Artificial Intelligence Tool Can Diagnose Colon Cancer

Detailed price information for Bausch Health Companies Inc (BHC-T) from The Globe and Mail including charting and trades.

Data Published in "The Red Journal" Validate Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier To Help Guide Therapy in Men with Intermediate-Risk Prostate Cancer - Vimarsana News

Data Published in "The Red Journal" Validate Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier To Help Guide Therapy in Men with Intermediate-Risk Prostate Cancer

Findings represent first validation of any gene expression biomarker for intermediate-risk patients using data from a randomized phase 3 clinical trial ... | May 2, 2023

Findings From Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier - Vimarsana News

Findings From Two Large-Scale, Real-World Data Sets Reinforce Clinical Utility of Veracyte's Decipher Prostate Genomic Classifier

Data from studies encompassing over 100,000 prostate cancer patients presented at American Urology Association 2023 Annual Meeting ... | April 29, 2023